학술논문
EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States
Document Type
Abstract
Author
Source
In Value in Health December 2022 25(12) Supplement:S89-S89
Subject
Language
ISSN
1098-3015